PRIFINIAL SOLUTION
PRIFINIAL SOLUTION
Authorised
- Prifinium bromide
Product identification
Medicine name:
PRIFINIAL SOLUTION
Active substance:
- Prifinium bromide
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Subcutaneous use
-
Intravenous use
Product details
Active substance and strength:
-
Prifinium bromide7.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA03AB18
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol S.A.
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 808/09/07/1484
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 20/03/2024